Regular Inhaled Corticosteroids Use May Protect Against Severe COVID-19 Outcome in COPD.

Int J Chron Obstruct Pulmon Dis · 2023 · PMC10421743 · PMID 37576828

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally non-significantno p-value reported

Results Regular ICS use was associated with only very slightly increased onset of COVID-19, hospitalization, ICU admission, and death in the overall whole population cohort and in the overall COPD subpopulation cohort, except for ICU admission (marginally non-significant HRs, up to 1.13); and no clear increase in the diagnosed sub-cohorts.

also in 1,493 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.